Investment Analysis News 1 December 2025

Macquarie Group (ASX:MQG) Stock Outlook for December 2025: Qube Bid, Nomura Deal and 2026 Forecast

Sydney – 2 December 2025 Macquarie Group Limited (ASX:MQG), Australia’s best‑known investment bank and global infrastructure investor, enters December 2025 in the middle of a major strategic reshaping. The stock is trading around A$193–194 per share, down roughly 10–14% for

2 December 2025

ARB Corporation Limited (ASX:ARB) Share Price, ASX Announcements and Analyst Forecasts – 2 December 2025

Published: 2 December 2025 (AEDT) ARB Corporation Limited (ASX:ARB), Australia’s best‑known 4×4 accessories group, is back in focus on Tuesday after a flurry of ASX announcements at the start of December and ongoing weakness in its share price following August’s

2 December 2025

ASX News · Financial Forecasts · Investment Analysis · Share Price · Stock Market

BHP Group Stock Outlook on 2 December 2025: Anglo Deal Shelved, China Iron Ore Standoff and Copper Growth

BHP Group Ltd (ASX: BHP, NYSE: BHP, LSE: BHP) heads into December 2025 with a familiar mix of strengths and headaches: record copper and iron ore output, a big new legal ruling over the Samarco dam disaster, a failed second

2 December 2025

Commodity Prices · Global Economy · Investment Analysis · Mining Industry · Stock Market

Pantoro Gold (ASX:PNR) Share Price Outlook: Tulla Stake Sale, Norseman Grades and 2026 Forecasts – 2 December 2025 Update

Pantoro Gold Limited (ASX:PNR) has just delivered one of those classic market plot twists: strong drilling results and booming gold prices on one side, a large shareholder selldown and a sharp share price drop on the other. On 2 December

2 December 2025

ASX Updates · Financial Forecasts · Gold Mining · Investment Analysis · Stock Market

Bank of Nova Scotia (BNS) Stock Near 52‑Week High: Davivienda Deal, Q4 2025 Earnings Preview and 2026 Forecast

As of December 2, 2025, Bank of Nova Scotia stock (Scotiabank, TSX: BNS, NYSE: BNS) is trading close to its 52‑week high, just hours before it reports fourth‑quarter 2025 earnings. At the same time, the bank has closed a major

2 December 2025

Banking · Earnings Preview · Financial Forecast · Investment Analysis · Stock Market

Cintas Stock (CTAS) on December 1, 2025: Price, Q1 2026 Earnings Beat, Dividend Hike and 2026–2028 Forecast

Cintas Corporation (NASDAQ: CTAS) heads into December 2025 as a classic “quality compounder” that has finally pulled back from record highs. The uniform and facility services specialist just delivered another beat‑and‑raise quarter, announced a fresh $1 billion buyback, and extended

2 December 2025

Dividends · Earnings Reports · Financial Forecasts · Investment Analysis · NASDAQ:CTAS · Stock Market

Bristol-Myers Squibb (BMY) Stock Today: Lawsuit Shock, Breyanzi Momentum and 2026 Forecast

Bristol-Myers Squibb (NYSE: BMY) has suddenly become one of the most eventful big pharma names to watch as of December 1, 2025. A major lawsuit has been allowed to proceed, new cell therapy approvals are landing, hematology data at ASH

2 December 2025

Investment Analysis · Lawsuits · Market Forecast · NYSE:BMY · Pharmaceutical Industry · Stocks

CME Group (CME) Stock: Outage Fallout, Record Volumes and 2026 Price Targets Explained

Updated December 1, 2025 CME Group Inc. (NASDAQ: CME), the world’s largest derivatives exchange operator, is ending 2025 on a complicated note. On one hand, the company is posting record volumes in key asset classes, rolling out new crypto benchmarks,

2 December 2025

Financial News · Investment Analysis · Market Trends · NASDAQ:CME · Stock Market · Trading Platforms

KKR Stock Today (December 1, 2025): Earnings Beat, Analyst Targets and Private Credit Stress Test

As of Monday, December 1, 2025, KKR & Co. Inc. (NYSE: KKR) is trading around $122 per share, having bounced back from its autumn lows but still sitting roughly 28% below its 52‑week high of $170.40 set in late January.

1 December 2025

Earnings Reports · Financial News · Investment Analysis · NYSE:KKR · Private Credit · Stock Market

HCA Healthcare (HCA) Stock on December 1, 2025: Near All‑Time Highs, Upgraded Guidance and What Comes Next

Date: December 1, 2025 – NYSE: HCA HCA Healthcare stock snapshot on December 1, 2025 HCA Healthcare, Inc. (NYSE: HCA), the largest for‑profit hospital operator in the United States, continues to trade near record territory as December begins. Barchart’s latest

1 December 2025

Financial News · Healthcare Stocks · Investment Analysis · Market Trends · NYSE:HCA · Stock Market

AbbVie (ABBV) Stock in December 2025: Atogepant Breakthrough, Q3 Beat and 2026 Outlook After Medicare Price Cuts

AbbVie Inc. (NYSE: ABBV) heads into December 2025 as one of the world’s largest healthcare companies, with new migraine data, fresh oncology approvals, a raised 2025 profit forecast and looming U.S. drug‑pricing reforms all shaping sentiment around the stock. The

1 December 2025

Earnings Reports · Healthcare Innovation · Investment Analysis · Pharmaceuticals · Stock Market

Broadcom Stock After the Bell: AVGO Pulls Back From Highs Even as Wall Street Lifts AI-Driven Price Targets

Broadcom stock (NASDAQ: AVGO) cooled off on Monday, December 1, 2025, giving back part of its recent AI-fueled rally even as major Wall Street firms raised their price targets and doubled down on the long-term story. After a torrid run

1 December 2025

Earnings Reports · Investment Analysis · Stock Market · Technology Stocks · Wall Street

Investment Analysis News 1 December 2025 - 2 December 2025